Clinical Trials Browser

INDUSTRY × Lymphoma × Bortezomib × Clear all

Lymphoma, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT00791011 2014-03-05

Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat

Phase 1 Completed

33 enrolled

Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT00085696 2008-02-11

VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma

Phase 2 Completed

66 enrolled

Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, B-Cell

Clinical Trials

A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies

Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat

VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma